lg-and-shaker-to-upgrade-ac-production-facility-in-saudi-arabia-with-innovative-automation-tech

LG and Shaker To Upgrade AC Production Facility in Saudi Arabia With Innovative Automation Tech

 

LG Electronics (LG) and Al Hassan Ghazi Ibrahim Shaker Co. (Shaker), Saudi Arabia’s leading importer, manufacturer and distributor of air conditioners and home appliances, have announced new investment in their joint-venture air conditioner (AC) production facility in Riyadh, Saudi Arabia. Opening a new era in the local manufacturing industry, the LG-Shaker plant will deploy industrial robots and artificial intelligence (AI) technology to automate the production process and optimize operational efficiency.

The adoption of cutting-edge automation technology will result in increased output and enable the plant to produce components that are now sourced, in part, from external providers. With the far-reaching upgrades to its facility, LG-Shaker will accelerate manufacturing capabilities and reduce production costs, boosting its competitiveness in the Saudi AC market, which is one of most important in the Middle East and is expected to grow by two percent over the next three years.

“This investment in cutting-edge production technology further cements our long-term relationship,” said Mohammed Ibrahim Abunayyan, chief executive officer at Al Hassan Ghazi Ibrahim Shaker Co. “We will continue to strengthen our partnership to bring consumers the latest life-enhancing innovations, and to contribute to the growth of domestic manufacturing in Saudi Arabia.”

Since commencing operation in 2018, the LG-Shaker manufacturing facility in Riyadh has widened the availability of high-performance LG residential and system air conditioners across the Middle East and North Africa, including the Gulf states and Egypt. Representing LG’s commitment to the communities where it operates, the AC production facility has aided in the development of a robust local manufacturing sector, in line with the goals of Saudi Arabia’s Saudi Vision 2030 and National Industrial Development and Logistics Vision (NIDLP).

“Adopting robotics and AI in our AC manufacturing plant will enable LG-Shaker to scale up in-house production and overall capacity, giving us better control of our supply chain and enhancing our ability to serve customers in the region,” said Ilhwan Lee, president of LG Electronics Middle East and Africa. “With stable production and increased output based on our long-standing partnership, LG can rapidly meet market demand and fast-changing consumer needs.”

bosch-commemorates-100-years-of-bosch-car-service

Bosch commemorates 100 years of Bosch Car Service

 

Bosch Car service, the principal Bosch Workshop service brand in the Bosch Automotive Aftermarket portfolio, commemorates 100 years of its presence as the world’s leading multi-brand car service workshop. From establishing the first official Robert Bosch AG installation and Repair workshop based in Hamburg in the year 1921, Bosch Car Service presently has a footprint of more than 15,000 workshops across 150 countries.

Bosch Car Service network partners benefit from Bosch’s ever growing expertise in diagnostic technology, availability of high quality and genuine spare parts and technical training for its workshop technicians. A qualification system within the Bosch Service Excellence program, including regular audits and service quality assessments, ensures the high quality of Bosch Car Service workshop partners. Car drivers benefit from genuine Bosch parts, sound technical know-how and efficient services of the workshop personnel who are up to date with regular training courses offered by Bosch. As a leading global supplier of technology and services, Bosch is one of the most important drivers of innovation in the field of mobility, which also benefits the Bosch Car Service brand, its network partners, and their customers.

“Bosch Car Service (BCS) in India has been growing at a very strong pace clocking a high double digit growth in 2020 over the previous year,” says Anjan Kumar. R – Regional President, Bosch Automotive Aftermarket. “This is also the highest growth posted in the BCS network expansion across geographies, in the milestone marking 100 years of presence, despite prevailing COVID challenges. Our value proposition towards passenger car workshops, have been strengthened over the last many months. This has been a major attraction for many OEM workshops across the country to convert to a Bosch Car Service workshop especially the recent outlets in Mumbai, Chandigarh, Chennai and Ahmedabad. Now is the best time for independent workshops to join a 100 year old strong network with the expertise of running a global multi brand car service concept. We offer comprehensive services namely vehicle diagnosis, wide range of spare parts, technical service and support to car owners that are at par with leading OEMs across the country. Importantly, while achieving the 100 years milestone, we have also created futuristic digital ecosystem for multi-brand workshops – an ecosystem beyond compare.”

Bosch Car Service presently has close to 250 touchpoints across India including the company-owned company-operated Bosch Car Service with state-of-the-art facilities, established in Bengaluru in 2017. The CoCo workshop serves as a centre of competence and a lighthouse to test-try and market all the value propositions before launching the same at an all-India level.

Bosch currently offers value enhancement to its network, through diverse cooperation models with leading players such as 3M, ITW, Mahindra Insurance Brokers Limited, Assurant India, Gates Unitta India, and many more tie-ups in the offing. Alliances of such kind enable improved accessibility and affordability for managing the operations of the workshops.

100 years since opening the first Bosch repair workshop, Bosch Car Service brand is a leader in the independent workshop market as modern full-service provider. Bosch is commemorating this success story with an optimistic look at the future: the objective is to further expand its network count by targeting significant growth in India, coordinate with customers and workshop partners on the basis of digital solutions and smart use of data, and reinforce its position as a reliable and innovative mobility partner across the world, both today and in the future. By offering comprehensive vehicle repair solutions, service and a plethora of value propositions, Bosch Car Service is your workshop next door ‘For everything your car needs.’

medical-cartridges-market-revenue-to-hit-$1,691.1-million-by-2030-says-p&s-intelligence

Medical Cartridges Market Revenue to Hit $1,691.1 Million by 2030 says P&S Intelligence

 

With the increasing prevalence of acute and chronic diseases of all types, be it infection, autoimmune, metabolic, systemic, or cancer, the pharmaceutical industry is booming. As a result, the global medical cartridges market will grow from $920.8 million in 2020 to $1,691.1 million by 2030, at a 6.4% CAGR between 2021 and 2030. A lot of the drugs are given via the parenteral route, which is why the demand for cartridges, syringes, and vials is increasing.

Around 16 billion injections are given every year for contraceptive, blood transfusion, immunization, and curative purposes, according to the World Health Organization (WHO). In this regard, the rising demand for prefilled syringes is driving the medical cartridges market, as the drug inside such devices is essentially contained in a cartridge. Prefilled syringes help prevent needlestick injuries and minimize the wastage of drugs.

Key Findings of Global Medical Cartridges Market

  • Glass cartridges continue to be preferred over plastic variants
  • Expanding pharma sector major growth driver for market
  • Europe most-productive region for industry players
  • Future investment opportunities galore in APAC
  • Cartridges being increasingly adopted in diagnostic procedures
  • Market players augmenting their production output

Get the Sample Copy of this Report at @ https://www.psmarketresearch.com/market-analysis/cartridges-market-outlook/report-sample

Due to the COVID-19 pandemic, the medical cartridges market is witnessing slow growth, as the lockdowns implemented around the world led to the shutdown of cartridge-manufacturing plants. Additionally, social distancing measures and movement restrictions meant that pharmaceutical representatives could not conduct face-to-face interactions with healthcare workers. Moreover, regulatory authorities have, for the moment, stopped approving pharmaceutical products, while many clinical trials have also been halted.

The glass bifurcation is expected to witness the faster growth in the medical cartridges market in the coming years, based on material type. Being inert, glass prevents reactions between the cartridge surface and the drug within. Additionally, glass stops volatile substances from penetrating the surface and mixing with the drug.

Browse detailed report with COVID-19 impact analysis on Medical Cartridges Market Research Report: By Material Type (Glass, Plastic), Size (Less than 3 ml, 3 ml to 5 ml, 6 ml to 10 ml, More than 10 ml), End User (Pharmaceutical and Biotech Companies, Biomedical Research Organizations) – Global Industry Revenue Estimation to 2030 @ https://www.psmarketresearch.com/market-analysis/cartridges-market-outlook

In the past, the end user segment of the medical cartridges market was dominated by pharmaceutical and biotech companies. With the growth of the pharma sector, drug, pen injector, and on-body injector manufacturers are increasingly using cartridges. In this regard, the rising adoption of pen injectors, especially by diabetics, is propelling the advance of this category, as are the technological advancements in drug delivery devices.

Make enquiry about this report at @ https://www.psmarketresearch.com/send-enquiry?enquiry-url=cartridges-market-outlook

Presently, Europe generates the highest revenue in the medical cartridges market due to the increasing prevalence of diabetes, itself, in part, owing to the rise in the number of obese people. In the near future, the demand for cartridges will likely surge the most rapidly in Asia-Pacific (APAC). The region is witnessing a boom in its geriatric population, number of people suffering from diabetes, and healthcare expenditure.

The most-significant players in the global medical cartridges market are Stevanato Group, Gerresheimer AG, SCHOTT AG, Nipro Corporation, Thermo Fisher Scientific Inc., Baxter International Inc., Merck KGaA, Pierrel S.p.A., Transcoject GmbH, Novocol Pharma, and AptarGroup Inc.

Browse Other Related Reports

Prefilled Syringes Market Report – Globally, Europe contributed the highest revenue to the prefilled syringes market in 2020, because of the high incidence of non-communicable diseases such as cancer, cardiovascular diseases, and diabetes in the region. In the future years, the market will demonstrate the fastest growth in Asia-Pacific. This will be because of the surging healthcare expenditure in the major Asian countries and the growing incidence of chronic diseases in the region.

Human Insulin Market Report – Geographically, the human insulin market is predicted to exhibit explosive growth in the Asia-Pacific region in the forthcoming years, on account of the rising incidence of diabetes, growing adoption of sedentary lifestyles, unhealthy eating habits of people, and increasing geriatric population in the regional countries such as India and China.

gastroretentive-drug-delivery-systems-market-size-worth-$197-billion-by-2028:-grand-view-research,-inc.

Gastroretentive Drug Delivery Systems Market Size Worth $19.7 Billion By 2028: Grand View Research, Inc.

 

The global gastroretentive drug delivery systems market size is estimated to reach USD 19.7 billion by 2028, registering a CAGR of 6.4%, according to a new report by Grand View Research, Inc. Gastroretentive Drug Delivery Systems (DDSs) offer possible advantages for the drug with poor bioavailability, as their absorption is restricted to the upper Gastrointestinal Tract (GIT) and can be delivered proficiently. Hence enhancing absolute bioavailability and maximizing its absorption is expected to boost market growth during the forecast period.

Key suggestions from the report:

  • The floating drug delivery systems held the largest market share in 2020
  • These systems have a lower density than gastric fluids and hence stay buoyant in the stomach without altering the gastric emptying rate for a long time
  • The liquid dosage form segment is expected to grow at the fastest rate during the forecast period due to the availability of a wide range of liquid-based gastroretentive products in treating all types of gastric disorders
  • The online pharmacies segment is predicted to witness the fastest growth rate over the forecast timeframe as they offer a wide range of options along with in-depth drug information
  • North America held the largest market share and is anticipated to maintain its dominance over the forecast period
  • This is attributable to the growing prevalence of H. Pylori infection, increasing R&D expenditure, and rising technological advancements in gastroretentive DDSs.

Read 150 page research report with ToC on “Gastroretentive Drug Delivery Systems Market Size, Share & Trends Analysis Report By Type (Tablets, Liquid, Capsule), By Dosage Form, By Distribution Channel, By Region, And Segment Forecasts, 2021 – 2028” at: https://www.grandviewresearch.com/industry-analysis/gastroretentive-drug-delivery-systems-market

Several advantages of these DDSs include curative efficiency and an increase in the bioavailability of drugs. The controlled and systematic DDS minimizes the chances of medicine overexposure at the diseased site. It also offers higher efficiency owing to reduced counter activity by the body. Hence, various advantages associated with gastroretentive DDSs are expected to foster the overall market progression.

The DDS sustains the release of drugs and avails local therapy in the small intestine and stomach. The method is useful in the treatment of various disorders related to the small intestine and stomach. Rising cases of stomach and small intestine-related disorders are anticipated to foster the demand for such efficient DDSs. According to the Endoscopy Center, each year around 62.0 million people are diagnosed with digestive disorders. The prevalence of most digestive disorders increases with age, creating demand for novel healthcare systems among adults and the geriatric population.

These DDSs are effective in treating duodenal and gastric ulcers, including esophagitis, by eliminating deeply buried helicobacter pylori from the submucosal tissue of the stomach. Apart from this, GRDDSs release the medicine slowly in the stomach and preserve its effective concentration in systemic circulation for a prolonged period of time. Hence, the above-mentioned factors are predicted to augment market expansion.

Grand View Research has segmented the global gastroretentive drug delivery systems market on the basis of type, dosage form, distribution channel, and region:

  • Gastroretentive DDS Type Outlook (Revenue, USD Million, 2016 – 2028)
    • High Density Systems
    • Expandable Drug Delivery Systems
    • Bioadhesive Drug Delivery Systems
    • Floating Drug Delivery Systems
    • Others
  • Gastroretentive DDS Dosage Form Outlook (Revenue, USD Million, 2016 – 2028)
    • Tablets
    • Liquid
    • Microspheres
    • Capsule
    • Others
  • Gastroretentive DDS Distribution Channel Outlook (Revenue, USD Million, 2016 – 2028)
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • Gastroretentive DDS Regional Outlook (Revenue, USD Million, 2016 – 2028)
    • North America
      • U.S.
      • Canada
    • Europe
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
    • Asia Pacific
      • China
      • Japan
      • India
      • Australia
      • South Korea
    • Latin America
      • Brazil
      • Mexico
      • Argentina
      • Columbia
    • Middle East & Africa
      • South Africa
      • Saudi Arabia
      • UAE.

List of Key Players of Gastroretentive Drug Delivery Systems (DDSs) Market

  • F. Hoffmann La Roche
  • Ranbaxy
  • GlaxoSmithKline
  • Pharmacia
  • Depomed
  • Alcon, Inc.
  • Lupin
  • Galanix
  • Sun Pharma.

Find more research reports on Medical Devices Industry, by Grand View Research:

  • Gastrointestinal Therapeutics Market – The global gastrointestinal therapeutics market size was valued at USD 51.9 billion in 2016 and is slated to expand at a lucrative CAGR of 6.6% over the forecast period. Increasing adoption of biologics for treatment of gastrointestinal diseases is the primary driver of the market.
  • Gastrointestinal Stents Market – The global gastrointestinal stents market size was valued at USD 314.8 million in 2016 and is expected to grow at a CAGR of 4.7% over the forecast period. Increasing geriatric population who have stomach or digestive cancer are driving the growth of the market.
  • Enteral Feeding Devices Market – The global enteral feeding devices market size was valued at USD 2.41 billion in 2018 and is expected to grow at a CAGR of 5.8%. Growing demand from home care sector, prevalence of chronic diseases, incidence of preterm birth, and growing geriatric population are driving the growth.
infosys-to-create-1,000-digital-jobs-in-the-uk-to-fuel-post-pandemic-growth

Infosys to Create 1,000 Digital Jobs in the UK to Fuel Post-Pandemic Growth

 

Infosys (NYSE: INFY), a global leader in next-generation digital services and consulting, today reinforced its commitment to supporting UK’s economic recovery and growth by announcing plans to hire 1,000 workers in the country over the next three years.

New hires will be working at the cutting edge of innovation in the digital space, including cloud computing, data and analytics, artificial intelligence, open source technologies and enterprise services to support some of the world’s largest organizations navigate their digital journeys. The company will provide critical training and mentoring opportunities for the fresh hires.

Recognized as a Top Employer globally and ranked among the top five employers in the UK for 2021, the new team members will join a world-class workforce spanning Infosys’ design studio in Shoreditch, its innovation center in Canary Wharf and proximity centres in Nottingham and other client locations across the UK.

To ensure a diverse talent pool and support the upskilling of the industry’s future leaders, a large proportion of the workforce will be hired from recently graduated students from leading colleges and universities in the UK. The company will also hire experienced professionals from technology and consulting with deep sector expertise who will be able to support local businesses in their digital journeys and lead a robust workforce for the future.

Salil Parekh, CEO, Infosys, said, “While the talent gap has been looming, the events of the past year have exacerbated the need for vital digital skills as businesses have rapidly accelerated their digital transformation. Bridging the digital divide and making quality digital education accessible to every citizen are vital to the establishment of a robust future workforce, and the UK’s economic recovery. Our commitment to the UK is to support both recovery and growth through digital acceleration, hiring new talent, and supporting the development and reskilling of existing talent to meet evolving economic demands. We continue to partner with universities across the UK to nurture the next generation of digital leaders and continually strive to close the skills gap, investing in a brighter future for everyone.”

Boris Johnson, UK Prime Minister, said, “This investment from Infosys is a vote of confidence in the UK and its technology sector and will help that sector scale new heights – creating the jobs of the future. We need more firms like Infosys with a commitment to investing in people to help the UK build back better.”

xiamen-a-hotbed-for-investment

Xiamen a Hotbed for Investment

 

This is a news report from China Daily:

A global investment promotion conference marking the 100th anniversary of the founding of Xiamen University was held in Xiamen, East China’s Fujian province, on April 7.

Agreements for 32 major industrial projects were inked, involving a combined investment of 43.9 billion yuan ($6.7 billion). Eleven of the projects are worth more than 1 billion yuan each and cover various fields such as semiconductors, bio-medicine, hotels, and modern logistics.

A program to encourage XMU’s alumni to invest in Xiamen was also launched at the conference, aiming to attract the alumni to contribute to the city’s high-quality development by bringing in more resources.

Since the program was initiated in September 2020, 511 projects led by XMU’s alumni had signed up for the program by April 5, involving a combined investment of 164.72 billion yuan.

Xiamen boasts a favorable environment for living and starting businesses,” said Zhao Haiying, an alumna of XMU and chairwoman of Femisci, a beauty and healthcare company.

Zhao, cooperating with SignalChem Lifesciences Co, a Canada-based clinical-stage company, signed an agreement to set up the company’s China headquarters in Xiamen’s Haicang district. It will include research and development platforms for protein engineering technology, and targeted therapies.

“Considering the strong scientific research capacity of XMU and the solid foundation of Xiamen’s biomedicine industry, I have full confidence in the future development of our project,” Zhao added.

A pioneer in attracting investment

As one of the country’s first four special economic zones and a key hub along the 21st Century Maritime Silk Road, Xiamen has led China in reform and opening-up, becoming a pioneer in attracting investment and innovating its economy.

The city signed 8,411 projects with a combined investment of 1.6 trillion yuan in 2020. It also led Fujian province in the actual use of foreign capital, which accounted for 47.7 percent of the province’s total.

Chinese startup Lixiang, also known as CHJ Automotive, and Tencent Cloud, the cloud computing unit of Chinese tech giant Tencent, also set up subsidiaries in Xiamen recently.

“We have eyed the high-end and new economy industries due to limited land (Xiamen covers an area of some 1,700 square kilometers),” said Huang Heming, director of the city’s commerce bureau, in an interview with ThePaper, a Shanghai-based online news portal.

To attract investment, the local government has spared 1,335 hectares of land for industrial use and 2.96 million square meters of office buildings for the modern service industry. The city also offers tailored solutions for industrial companies in terms of land use and leads the country in speeding up related administrative procedures.

A city of the new economy

Behind Xiamen’s economic growth are mainly 12 industrial chains, each with a value of at least 100 billion yuan.

“We are building a city of the new economy,” said Huang.

The city has seen increasing capacity for independent innovation in high-end manufacturing industries, such as flat-panel displays, semiconductors, and integrated circuits, as well as new materials, as projects like MicroLED R&D center sponsored by TCL China Star Optoelectronics Technology Co and the Cross-Strait Tsinghua Research Institute signed or started operating.

As one of the cradles of China’s internet and games, Xiamen’s software industry generated 197.2 billion yuan in revenue last year, accounting for nearly 58 percent of the provincial total. Among its 10 listed companies, five are among the top 100 internet companies in China.

In addition, booming strategic emerging industries have also become a highlight of Xiamen’s growth. Taking the biomedicine sector as an example, the city currently has a dozen national laboratories, 297 national high-tech companies, and 10 listed companies, with a combined revenue of nearly 100 billion yuan.

Breakthroughs have also been made in attracting investment in the film, television, and culture industries, as industrial leaders like news portal Toutiao, podcast app Himalaya FM and box office tracker Maoyan have set up operations in Xiamen.

The new economy characterized by the digital economy is taking shape, with 79 projects worth 27.6 billion yuan settling in the city.

Xiamen has adhered to the concept of “creating a market for investment” to accelerate the growth of its new economy.

The local government has encouraged the information technology, education, health, urban management, transportation, and public security departments to offer abundant application scenarios and policy support to new business models focusing on big data, artificial intelligence, and the sharing economy.

The city has also seized development opportunities in the post-pandemic era, with several infrastructure projects involving 5G technology, big data, AI, and online medical treatment being signed or starting operations.

regulators-challenged-by-covid-19-pandemic-but-not-letting-businesses-off-the-hook,-nuix-survey-finds

Regulators Challenged by COVID-19 Pandemic but Not Letting Businesses Off the Hook, Nuix Survey Finds

Regulators worldwide have largely adjusted to the new circumstances brought about by the COVID-19 pandemic and maintained their focus on protecting consumers and markets, according to a new survey published by global software company Nuix (www.nuix.com). The report also highlights the importance of investigation readiness for regulators, highly regulated corporations and the legal and advisory firms they turn to for help.

Nuix’s 2021 Global Regulator Report: Best Practices for Financial and Competition Regulators Around the World is the result of a survey by Ari Kaplan Advisors (www.arikaplanadvisors.com) of 31 securities, financial services and competition regulators in 18 countries.

“Over the period I was doing the research, the regulators I spoke to were making significant adjustments to their own work practices and in the way they dealt with their target corporations as a result of the pandemic,” said Ari Kaplan, principal of Ari Kaplan Advisors and the report’s lead researcher and author.

“On the one hand, the regulators understood that their targets were operating in changed circumstances. But they also recognized that in tougher economic times, there is a greater temptation to do the wrong thing, such as the emergence of COVID-related fraud, and that called for greater vigilance.”

The survey examines financial and competition regulators’ investigative methods, preferred technology protocols, primary enforcement strategies, data sharing preferences and much more. As well as providing a wealth of data for regulators seeking to benchmark against their global peers, the report offers valuable intelligence for highly regulated corporations and their legal and advisory firms.

“One very interesting finding was that most regulators don’t provide any warning that an investigation is about to drop,” said Stuart Clarke, Nuix’s Regional Director for Northern Europe. “Throughout my career, I’ve seen that urgent, last-minute responses to regulatory investigations incur the greatest financial burden.

“This research clearly shows the return on investment for developing a regulator-ready strategy. Being regulator ready is not just about remaining compliant. You can dramatically reduce your risk by having a firm grasp of your regulatory environment and leveraging best-in-class technology to discover and investigate your data.”

Between March 20 and August 11, 2020, legal industry analyst Ari Kaplan interviewed 31 regulators responsible for securities, financial services and competition in 18 countries. To read the full report and related materials, visit www.nuix.com/Regulators-2021.

agricultural-biotechnology-market-revenue-worth-$106,870-million-by-2030,-says-p&s-intelligence

Agricultural Biotechnology Market Revenue Worth $106,870 Million by 2030, says P&S Intelligence

 

From 7.7 billion in 2019, the global population will reach 11.2 billion by 2100, according to the United Nations (UN). This is to be a key factor in the growth of the global agricultural biotechnology market revenue from $39,565.6 million in 2020 to $106,870.0 million by 2030, at a 10.7% CAGR between 2021 and 2030. This will be due to the burgeoning demand for food, which has already been putting immense pressure on the agrarian community for centuries.

In addition, with the expansion of human settlements, the availability of farmlands is reducing, which is why farmers are under intense pressure to make the most of what they have. This is fueling the agricultural biotechnology market advance by leading to the rising adoption of enhanced technologies for crop cultivation. Moreover, the rising disposable income of people is allowing them to purchase genetically modified (GM) crops, which are expensive.

Key Findings of Global Agricultural Biotechnology Market

  • Genome editing remains most-widely used technology
  • Consumption of transgenic seeds higher than of crop protection products
  • Adoption of biofuels key trend in industry
  • APAC to offer lucrative growth opportunities to agricultural biotech companies
  • Product launches and acquisitions strongest strategic measures
  • Market growing with rising population and its surging disposable income

Get the Sample Copy of this Report at @ https://www.psmarketresearch.com/market-analysis/agricultural-biotechnology-market/report-sample

The COVID-19 pandemic has significantly affected the agricultural biotechnology market due to the lockdowns and movement restrictions around the world. On account of the reduced demand for biofuel, its and its feedstock’s prices have dwindled. However, the demand for GM crops was not affected much, as the requirement for food for the 7.7 billion people on earth remained stable.

In the coming years, the genome editing category, under the technology segment, will continue to generate the highest agricultural biotechnology market revenue. With this technology, healthier crops, which stay unaffected by droughts and floods and are resistant to insects, can be produced. As a result, the genome editing technology is being extensively researched upon and adopted by the agrarian community.

Browse detailed report with COVID-19 impact analysis on Agricultural Biotechnology Market Research Report: By Technology (Genome Editing, DNA Sequencing, RNAi, Synthetic Biology, Biochip), Product (Transgenic Seeds, Crop Protection Products) – Global Industry Analysis and Growth Forecast to 2030 @ https://www.psmarketresearch.com/market-analysis/agricultural-biotechnology-market

The fastest growth in the agricultural biotechnology market is predicted to be seen in Asia-Pacific (APAC) during this decade. Being the most-populated region, APAC is witnessing the adoption of modern techniques for the augmentation of the agricultural yield. Moreover, extensive research and development (R&D) has led to the rapid uptake of GM crops in the region, which are increasingly receiving approvals from regulatory authorities.

Make enquiry about this report at @ https://www.psmarketresearch.com/send-enquiry?enquiry-url=agricultural-biotechnology-market

The most-significant players in the global agricultural biotechnology market are Syngenta AG, Performance Plants Inc., DuPont de Nemours Inc., Certis USA LLC, BASF SE, Bayer AG, Vilmorin & Cie, ADAMA Agricultural Solutions Ltd., Evogene Ltd., KWS SAAT SE & Co. KGaA, Novozymes A/S, and Global Bio-Chem Technology Group Company Limited.

Browse Other Related Reports

Genomics Market Report – The Asia-Pacific region is predicted to register the highest CAGR during the forecast period, as the number of research activities in the field to genomics is growing in countries including JapanIndia, and China. Both public and private organizations are providing funding for innovations in genome research.

Protein Extracts from Single Cell Protein Sources Market Report – The factor fueling the growth of the protein extracts from single cell protein sources market in the APAC region is the increasing animal feed production, on account of the soaring livestock production, in the regional countries. With the rising livestock production rate, the consumption of various nutrients such as protein is increasing rapidly across the region.

huawei’s-iaas-market-share-ranks-no.-2-in-china-and-among-the-top-5-in-the-global-market

Huawei’s IaaS Market Share Ranks No. 2 in China and Among the Top 5 in the Global Market

 

According to the recently released Gartner report Market Share: IT Services, Worldwide 2020 1, Huawei’s IaaS market share ranks No.2 in China and among the Top 5 in the global market in 2020.

HUAWEI CLOUD has developed a cloud infrastructure foundation based on the QingTian architecture to provide enterprises with basic cloud services featuring high performance, high stability, diverse compute power, and cloud-edge-device synergy. At the HUAWEI CLOUD Tech Summit in April 2021HUAWEI CLOUD released a new cloud infrastructure paradigm. Using the QingTian architecture, HUAWEI CLOUD provides developers with efficient, agile, and open cloud-native infrastructure, delivered through the distributed cloud to wherever needed. This supercharges service processes with intelligence and enables diverse industries to quickly implement full cloudification and full-stack intelligence.

HUAWEI CLOUD was one of the first vendors to invest in cloud-native technologies. HUAWEI CLOUD helped establish the Cloud Native Computing Foundation (CNCF) in 2015, and is the only founding member and the first platinum member of CNCF from ChinaHUAWEI CLOUD has been immersed in the cloud-native field and has contributed more than 130 core features to the CNCF community, ranking first in Asia in terms of code contribution and Maintainer seats. HUAWEI CLOUD also contributed the first cloud-native edge compute system KubeEdge, and the cloud-native batch compute solution Volcano.

By December 2020HUAWEI CLOUD had launched more than 220 cloud services and more than 210 solutions, developed more than 20,000 partners, attracted 1.8 million developers, and launched more than 4,000 applications in the Marketplace. Outside ChinaHUAWEI CLOUD has launched cloud data centers in SingaporeChileBrazilMexico, and Peru, working with partners to provide services in 45 availability zones across 23 regions worldwide.

laiye-closes-$50-million-in-series-c+-funding

Laiye Closes $50 Million in Series C+ Funding

 

Laiye, China’s leader in Intelligent Automation, has announced today it has raised $50 million in series C+ funding in a round jointly led by Ping An Global Voyager Fund and Shanghai Artificial Intelligence Industry Equity Investment Fund with participation from Lightspeed China Partners, Lightspeed Venture Partners, Sequoia Capital China and Wu Capital.

Over the past year, Laiye has accomplished several milestones through its innovative product offerings and fast developing ecosystem. Laiye accelerated its international expansion despite the pandemic and is now serving a growing customer base that consists of numerous Fortune 500 companies, governmental organizations, and SMBs. Laiye’s annual RPA software subscription revenue soared with an impressive 900% year-over-year growth. The Intelligent Automation vendor’s conversational AI product, Laiye Chatbot, also continued to garner favourable responses from the user community. These successes are in line with Laiye achieving positive cashflow for its enterprise business and profitability for chatbot business in Q4, 2020.

LI Wei, co-CEO and president of Laiye, stated that this round of funding will be primarily applied towards global expansion and product development to help businesses achieve end-to-end intelligent automation. Laiye aims to enhance its RPA offering with native AI capability, compatibility with more operating systems like Linux and Android and deployability on all major cloud platforms. The company will keep recruiting top talent to develop industry-specific solutions and strengthen its developer and partner ecosystem.

Laiye’s current global footprint spans across Asia, US and Europe with international partners including Microsoft, Deloitte, KPMG and Digital China. Also Laiye has successfully established its new overseas office in Singapore to serve as the headquarter of the Asia Pacific region. In its ongoing expansion, Laiye will seek to partner with prominent enterprises in South East Asia, and be cognizant of the expectations and technological trends prevalent in local regions in order to ensure its solutions are relevant to the target markets.

Jonathan Larsen, Ping An Group Chief Innovation Officer, and CEO of Ping An Global Voyager Fund which leads this round said,  “Laiye has established itself as a clear leader in China in an extremely fast growing and attractive space. Laiye’s solutions have particular resonance with financial institutions, which in China are generally just beginning to reap the rewards of RPA applications. Ping An is excited to partner with Laiye to help take it to the next phase of its growth story”.

WU Wei, MD of Shanghai Artificial Intelligence Industry Equity Investment Fund, Laiye’s latest investor, commented “Laiye has deep roots in RPA as well as AI technologies like deep learning, NLP and multi-modal interaction. Coupled with the capability to effectively land in-depth and comprehensive solutions, they can help organizations to efficiently build up their intelligent tools and business process solutions. We will continue supporting Laiye to enable more industry players in Shanghai and beyond to achieve successful digital transformation. ”

James Mi, founding partner from Lightspeed China which has been one of Laiye’s earliest investors, commented, “Since our investment in Laiye in the seed round, we have witnessed Laiye’s growth towards becoming China’s leader in intelligent automation and building China’s biggest developer community and partner ecosystem”.

Laiye currently has an expansive community with over 400,000 developers and more than 500 partners, primarily in China. They are quickly broadening their community outside China through partners like SAMART RAASPAL from Thailand.

Wang Guanchun, Chairman and CEO of Laiye, said, “Laiye has been growing its developer community by organizing RPA+AI competitions and launching a bot store that connects SMBs with automation needs to freelancing developers. Laiye aims to foster the world’s largest developer community for software robots and build the world’s largest bot marketplace in the next 3 years. And we plan to certify at least 1 million software robot developers by 2025. We believe that digital workforce and intelligent automation will reach all walks of life as long as more human workers can be up-skilled with knowledge in RPA and AI”.